PubRank

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Clinical Trial ID NCT01865617

PubWeight™ 20.66‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01865617

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 2014 2.84
2 Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy. Blood 2016 1.91
3 CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J Clin Invest 2016 1.75
4 Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies. Int J Hematol 2013 1.64
5 Adoptive immunotherapy for cancer or viruses. Annu Rev Immunol 2014 1.61
6 Chimeric antigen receptor-modified T cells derived from defined CD8(+) and CD4(+) subsets confer superior antitumor reactivity in vivo. Leukemia 2015 1.45
7 Driving CAR T-cells forward. Nat Rev Clin Oncol 2016 1.09
8 Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells. Sci Transl Med 2016 1.01
9 Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology 2014 0.96
10 Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy. Clin Cancer Res 2016 0.95
11 CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL). Ther Adv Hematol 2015 0.95
12 Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Mol Cancer 2015 0.94
13 Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches. Leukemia 2014 0.86
14 Synthetic biology in cell-based cancer immunotherapy. Trends Biotechnol 2015 0.84
15 Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances. Ther Adv Hematol 2015 0.82
16 Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors. World J Stem Cells 2015 0.78
17 Using gene therapy to manipulate the immune system in the fight against B-cell leukemias. Expert Opin Biol Ther 2015 0.77
18 Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapy. Immunotargets Ther 2015 0.75
19 Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology. Pediatr Blood Cancer 2015 0.75
Next 100